MANNKIND CORP Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
MANNKIND CORP (MNKD) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 156.95 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2026-08-05
- MANNKIND CORP share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2025 was 113.55K shares, a 10.37% decline from fiscal 2024.
- MANNKIND CORP share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2024 was 126.68K shares, a 43.74% decline from fiscal 2023.
- MANNKIND CORP share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2023 was 225.18K shares, a 34.69% decline from fiscal 2022.
- MANNKIND CORP share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2022 was 344.77K shares, a 54.90% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month |
|---|---|---|
| 2026-06-30 | 156.95K shares 10-Q · filed 2026-08-05 | |
| 2025-12-31 | 113.55K shares 10-K · filed 2026-02-26 | |
| 2024-12-31 | 126.68K shares 10-K · filed 2025-02-26 | |
| 2023-12-31 | 225.18K shares 10-K · filed 2024-02-27 | |
| 2022-12-31 | 344.77K shares 10-K · filed 2023-02-23 | |
| 2021-12-31 | 764.49K shares 10-K · filed 2022-02-24 | |
| 2020-12-31 | 183.90K shares 10-K · filed 2021-02-25 | |
| 2019-12-31 | 990.59K shares 10-K · filed 2020-02-25 | |
| 2018-12-31 | 531.55K shares 10-K · filed 2019-02-26 | |
| 2017-12-31 | 1.17M shares 10-K · filed 2018-02-27 | |
| 2016-12-31 | 199.89K shares 10-K · filed 2017-03-16 | |
| 2015-12-31 | 896.18K shares 10-K · filed 2016-03-15 | |
| 2014-12-31 | 355.70K shares 10-K · filed 2015-03-02 | |
| 2013-12-31 | 187.99K shares 10-K · filed 2014-03-03 | |
| 2012-12-31 | 485.06K shares 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |